29
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

Medium Chain Triglycerides (MCT) in the Treatment of Protein-losing Enteropathy and Malabsorption Syndromes

, M.D &
Pages 306-313 | Received 15 Dec 1966, Published online: 29 Nov 2016
 

Abstract

Patients with protein-losing enteropathy and other malabsorption syndromes were treated with a low fat diet supplemented with medium chain triglycerides (MCT). A total of 18 patients were studied.

In four out of five cases with protein-losing enteropathy a noticeable improvement of protein loss and steatorrhoea occurred. In the fifth patient, who had no steatorrhoea, improvement was slight.

In nine patients with steatorrhoea secondary to pancreatic insufficiency (three cases), Crohn’s disease (one), intestinal resection (one), intestinal resection + blind loop syndrome (one), postgastrectomy + enteropathy of undefined nature (one), sarcoidosis with mesenteric gland involvement (one), and generalized mastocytosis (one), clinical improvement followed the institution of MCT diet in every case, whereas steatorrhoea ceased in all except two with chronic pancreatitis.

In four patients with chronic intestinal disease without steatorrhoea the beneficial cffect of MCT varied. A low fat diet supplemented with MCT seems to represent an important advance in the medical management of a variety of malabsorption syndromes.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.